SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-21-005123
Filing Date
2021-02-16
Accepted
2021-02-16 21:54:01
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 form5.html 5  
1 FORM 5 form5.xml 5 3749
  Complete submission text file 0001140361-21-005123.txt   5216
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Issuer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 412 WEST 15TH STREET 9TH FLOOR NEW YORK NY 10019
Business Address
Yalamanchi Naveen (Reporting) CIK: 0001725743 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36829 | Film No.: 21642441